The Right to Try bill signed into law by President Trump on May 30th this year allows terminally ill patients residing in the U.S. to gain access to medicines that have passed Phase 1 of the FDA approval process but have not established efficacy in post Phase 1 clinical trial testing. Prior to Trump’s signing of the legislation 38 states had already enacted Right to Try laws.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,